Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
Menveo - Only diluent administered; Menveo - Only diluent administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Menveo - Only diluent administered) and inappropriate dose of vaccine administered (Verbatim: Menveo - Only diluent administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 28-APR-2025 The pharmacist stated that they had found a vial of the A component of Menveo (2 vials) in their fridge. As a result, they assumed that one of the five patients had only received the diluent portion of the vaccine, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered. The pharmacist mentioned that a physician had been considering re-vaccinating all five patients, but the pharmacist had been uncertain about this decision. The pharmacist had inquired about how soon the dose could be repeated.